Showing results (151-160 of 210) with videos related to

Sort By:
Pageof 21
Journal of Clinical Medicine|April 28, 2023
Rheumatoid Arthritis from Easy to Complex Disease: From the "2022 GISEA International Symposium"Simone Perniola, Maria Sole Chimenti, Francesca Romana Spinelli, et al.
Rheumatology (Oxford, England)|January 29, 2020
Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysisGiacomo De Luca, Corrado Campochiaro, Maria De Santis, et al.
Microvascular Research|September 19, 2020
Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvementGerlando Natalello, Giacomo De Luca, Laura Gigante, et al.
European Journal of Internal Medicine|July 12, 2022
C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritisGian Luca Erre, Fabio Cacciapaglia, Garifallia Sakellariou, et al.
European Journal of Internal Medicine|October 18, 2021
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study GroupFabio Cacciapaglia, Francesca Romana Spinelli, Matteo Piga, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 18, 2019
Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD studyDaniela Pugliese, Marco Daperno, Gionata Fiorino, et al.
Rheumatology (Oxford, England)|October 24, 2014
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosusAlessandra Bortoluzzi, Carlo Alberto Scirè, Stefano Bombardieri, et al.
Trials|March 24, 2026
An international, multicentre, interventional, randomised, assessor-blinded trial to MAXimise the METHotrexate therapy potential in patients with active rheumatoid arthritis (MethMax trial): study protocol for a randomised controlled trialKarolina Anderle, Daniela Sieghart, Martina Durechova, et al.
Mediators of Inflammation|February 28, 2018
Prevalence and Determinants of Peripheral Microvascular Endothelial Dysfunction in Rheumatoid Arthritis Patients: A Multicenter Cross-Sectional StudyGian Luca Erre, Matteo Piga, Anna Laura Fedele, et al.
Frontiers in Medicine|March 26, 2024
Retention rate of biologic and targeted synthetic anti-rheumatic drugs in elderly rheumatoid arthritis patients: data from GISEA registryAndreina Manfredi, Marco Fornaro, Chiara Bazzani, et al.
Pageof 21